Table 2

Univariate Cox Regression Analyses for OS, BCSS and RFS
Variables OS BCSS RFS
HR 95% CI P HR 95% CI P HR 95% CI P
Age 1.07 1.04-1.09 .000 1.05 1.02-1.09 .003 1.04 1.01-1.07 .012
Lymph node status
- vs. + 2.59 1.30-5.14 .007 5.57 1.85-16.78 .002 6.70 2.52-17.80 .000
Tumor size
>20 vs. ≤20 mm 2.53 1.31-4.89 .006 3.04 1.19-7.78 .02 3.14 1.34-7.10 .006
Ki67 3.00 1.51-5.96 .002 3.99 1.38-11.50 .01 1.68 0.82-3.44 .16
Grade 2.11 1.28-3.49 .004 5.14 2.03-13.00 .001 3.18 1.62-6.25 .001
HER 3.75 1-57-8.99 .003 7.69 2.98-19.86 .000 7.13 3.01-16.90 .000
ER 0.39 0.19-0.79 .009 0.23 0.10-0.55 .001 0.28 0.13-0.60 .001
CD163 in TS 2.66 1.28-5.55 .009 3.20 1.20-8.54 .02 2.12 0.83-5.39 .12
CD68 in TS 0.16 0.07-0.35 .000 15.2 5.45-42.45 .000 9.24 3.64-23.48 .000
CD163 in TN 0.32 0.04-2.37 .27 1.45 0.33-6.32 .62 1.06 0.25-4.55 .94
CD68 in TN 0.05 0.00-21.70 .33 0.44 0.00-169.12 .46 0.04 0.00-43.30 .37

Abbreviations: OS, overall survival; BCSS, breast cancer specific survival; RFS, recurrence free survival; HR, hazard ratio.

Medrek et al.

Medrek et al. BMC Cancer 2012 12:306   doi:10.1186/1471-2407-12-306

Open Data